0602830: BardPort MRI Implantable Port with 8F Groshong Single-Lumen Venous Catheter

Sign in to add this product to your favorites!
| Price: | $225.00 EACH |
|---|---|
| In Stock: | 0 eaches |
| Expiration: | In-Date |
We currently do not have this item in stock, but we can email you as soon as it is available.
Additional Details
M.R.I.® Implantable Port
0602830
- M.R.I. Implantable Port
- Groshong Radiopaque Silicone Single-Lumen Catheter, Distally-Valved with Preloaded Stylet, 8F, 50cm Effective Length
- (2) Catheter Locks
- Guidewire, J-Tip (3mm Radius) with Straightener, 0.035" x 45cm
- Introducer Needle, 18G x 70mm
- Introducer, Peel-Apart Sheath, 8F x 15cm with Vessel Dilator (1.0mm ID)
- Non-Coring Needle, 22G x 25mm, Right Angle
- Non-Coring Needle, 22G x 25mm, Straight
- Syringe, 12ml
- Tunneler
- Vein Pick
- Winged Infusion Set, 20G x 25mm
AccessGUDID Info
- FDA Product Code: LJT
- FDA Product Code Name: PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
- GMDN Term Code: 61494
- GMDN Term Name: Vascular port/catheter
- GMDN Term Description: A fully-implantable device assembly intended to provide access to arteries/veins (excludes coronary and intracerebral circulation) for infusion (e.g., chemotherapeutic agents, blood transfusions) and/or drainage (e.g., blood). It consists of: 1) a subcutaneous chamber, with a self-sealing puncturable septum for percutaneous insertion of a hypodermic needle; and 2) an attached catheter which passes into the arteries/veins. It may consist of two chambers attached to a dual-lumen catheter for simultaneous infusion. It is made of metal [e.g., titanium (Ti)] and/or synthetic polymers (e.g., silicone); disposable devices associated with implantation may be included.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
IN-DATE